» Articles » PMID: 29117350

Conducting Patient-Pathway Analysis to Inform Programming of Tuberculosis Services: Methods

Overview
Journal J Infect Dis
Date 2017 Nov 9
PMID 29117350
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Patient-centered care is a central pillar of the World Health Organization's End TB Strategy. Understanding where patients access health services is a first step to planning for the placement of services to meet patient needs and preferences. The patient-pathway analysis (PPA) methodology detailed in this article was developed to better understand the alignment between patient care seeking and tuberculosis service availability. A PPA describes the steps that people with tuberculosis take from the initial care visit to cure. The results of a PPA reveal programmatic gaps in care seeking, diagnosis, treatment initiation, and continuity of care. They can be used as inputs to an evidence-based process of identifying and developing interventions to address the gaps in patient care. This paper summarizes the steps to conduct a PPA and serves as the basis for understanding country case studies that profile the use of PPA.

Citing Articles

Tuberculous meningitis patient pathways and delays to diagnosis in Indonesia: a retrospective cohort study.

Nijman G, Imran D, Dian S, Ganiem A, Estiasari R, Maharani K BMJ Public Health. 2025; 1(1):e000052.

PMID: 40017887 PMC: 11812694. DOI: 10.1136/bmjph-2023-000052.


Mapping Patient Pathways in Tuberculosis Care: Insights From Gujarat and Jharkhand States of India.

Deep K, Gwalani R, Singh D, Baliyan S, Thakur J, Kanwar D Cureus. 2024; 16(8):e67716.

PMID: 39318901 PMC: 11421198. DOI: 10.7759/cureus.67716.


Exploring heterogeneity in coxarthrosis medication use patterns before total hip replacement: a State Sequence Analysis.

Novelli A, Frank-Tewaag J, Franke S, Weigl M, Sundmacher L BMJ Open. 2024; 14(9):e080348.

PMID: 39289022 PMC: 11409302. DOI: 10.1136/bmjopen-2023-080348.


Exploring the Role of the Private Sector in Tuberculosis Detection and Management in Lima, Peru: A Mixed-Methods Patient Pathway Analysis.

Wippel C, Farronay S, Gilbert H, Millones A, Acosta D, Torres I Am J Trop Med Hyg. 2024; 111(1):168-175.

PMID: 38744270 PMC: 11229640. DOI: 10.4269/ajtmh.23-0504.


Treatment seeking behaviours, antibiotic use and relationships to multi-drug resistance: A study of urinary tract infection patients in Kenya, Tanzania and Uganda.

Sado K, Keenan K, Manataki A, Kesby M, Mushi M, Mshana S PLOS Glob Public Health. 2024; 4(2):e0002709.

PMID: 38363770 PMC: 10871516. DOI: 10.1371/journal.pgph.0002709.


References
1.
Wells W, Ge C, Patel N, Oh T, Gardiner E, Kimerling M . Size and usage patterns of private TB drug markets in the high burden countries. PLoS One. 2011; 6(5):e18964. PMC: 3087727. DOI: 10.1371/journal.pone.0018964. View

2.
Bronner Murrison L, Ananthakrishnan R, Swaminathan A, Auguesteen S, Krishnan N, Pai M . How do patients access the private sector in Chennai, India? An evaluation of delays in tuberculosis diagnosis. Int J Tuberc Lung Dis. 2016; 20(4):544-51. DOI: 10.5588/ijtld.15.0423. View

3.
Fekadu L, Hanson C, Osberg M, Makayova J, Mingkwan P, Chin D . Increasing Access to Tuberculosis Services in Ethiopia: Findings From a Patient-Pathway Analysis. J Infect Dis. 2017; 216(suppl_7):S696-S701. PMC: 5853928. DOI: 10.1093/infdis/jix378. View

4.
Masini E, Hanson C, Ogoro J, Brown J, Ngari F, Mingkwan P . Using Patient-Pathway Analysis to Inform a Differentiated Program Response to Tuberculosis: The Case of Kenya. J Infect Dis. 2017; 216(suppl_7):S714-S723. PMC: 5854007. DOI: 10.1093/infdis/jix381. View